|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash Flows from Operating Activities: | |||||
| Net loss | |||||
| Less: gain from discontinued operations, net of $63,000 in tax | |||||
| Net loss from continuing operations | |||||
| Reconciliation of net loss to net cash used in operating activities: | |||||
| Stock-based compensation | |||||
| Changes in operating assets and liabilities: | |||||
| Prepaid expenses and deposits | |||||
| Other receivables | |||||
| Related party payable | |||||
| Accounts payable and accrued expenses | |||||
| Net cash used in operating activities - continuing operations | |||||
| Net cash used in operating activities - discontinued operations | |||||
| Deferred revenue | |||||
| Net cash used in operating activities | |||||
| Net cash provided by investing activities - discontinued operations | |||||
| Cash Flows from Financing Activities: | |||||
| Proceeds from issuance of common stock, prefunded warrants and warrants, net | |||||
| Proceeds from stock options exercise | |||||
| Proceeds from exercise of warrants and stock options | |||||
| Net cash provided by financing activities | |||||
| Net (decrease) increase in cash, cash equivalents, and restricted cash | |||||
| Cash, cash equivalents, and restricted cash at beginning of the year | |||||
| Cash, cash equivalents, and restricted cash at end of the year | |||||
| Issuance of common stock as commitment fee for future financing | |||||
Loading...